G. Galati et al., In vivo administration of GM-CSF promotes the clearance of apoptotic cells: effects on monocytes and polymorphonuclear leukocytes, J LEUK BIOL, 67(2), 2000, pp. 174-182
The clearance of apoptotic cells is crucial to avoid chronic inflammation a
nd autoimmunity, Little is known about the factors that regulate it in vivo
. We show that granulocyte-macrophage colony-stimulating factor (GM-CSF) ad
ministration to carcinoma patients confers to their leukocytes a significan
tly higher ability to phagocytose apoptotic cells than before (P < 0.005),
GM-CSF increased the concentration of monocytes and polymorphonuclear leuko
cytes in the peripheral blood and activated circulating polymorphonuclear l
eukocytes, Both effects abated early after treatment, whereas phagocytosis
of apoptotic cells was still significantly higher after 18 days compared wi
th basal values (P < 0.005 and P < 0.025 for monocytes and polymorphonuclea
r leukocytes, respectively). On in vitro phagocytosis of apoptotic cells mo
nocytes, but not polymorphonuclear leukocytes, up-regulated MHC class II me
mbrane expression, These findings are consistent with the possibility that
GM-CSF endows both scavenger and antigen-presenting leukocytes with the abi
lity to internalize apoptotic turner cells.